ArticleResearch square2023

Clinical Response to a PARP Inhibitor and Chemotherapy in a Child with BARD1-Mutated Refractory Neuroblastoma: A Case Report.

Maggie Cupit-Link et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.